TREATMENT OF HOMOLOGOUS RECOMBINATION PROFICIENT OVARIAN CANCER AND PARP INHIBITOR-RESISTANT TUMORS USING PP2A RE-ACTIVATION STRATEGIES
$702,000FY2022Department of the ArmyDOD
Regents Of The University Of Michigan
Regents Of The University Of Michigan